Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_132aa5ddba376cda52c2bedb26765245 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-2821 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-805 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-8139 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6896 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-70539 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-74 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-805 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-81 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-37 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N27-62 |
filingDate |
2003-08-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2015-07-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6034a243edfdc6e8c4d0c8629dfb8503 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_23c0ffe6740981e33f1d6ceeb5acdd56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_587bb505db234724ef500577ac04a300 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_37fe15fdf71cc6c071f5bbb41c4323ea http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0e514b64d9406ce76fcbae96ad2c287f |
publicationDate |
2015-07-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
CA-2745569-C |
titleOfInvention |
Biomarkers for diagnosing alzheimer`s disease |
abstract |
A method for assessing the state of Alzheimer's disease in patients is disclosed. A method for monitoring the progression of Alzheimer's disease in patients is also disclosed. The method applies detection of specific markers in body fluids (e.g. CSF), using mass spectrometric analysis (SELDI-TOF MS). The specific markers are: human cystatin C, human beta-2-microglobulin, human myoglobin neurosecretory protein VGF or fragments of these proteins. |
priorityDate |
2002-08-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |